BioUtah Announces Early Bird Registration for 2025 Utah Life Sciences Summit Featuring Top Federal Regulators
BioUtah's upcoming 2025 Utah Life Sciences Summit brings together industry leaders and federal regulators to address critical healthcare innovation challenges in one of the nation's fastest-growing life sciences hubs.
BioUtah has opened Early Bird registration for the 2025 Utah Life Sciences Summit presented by Mayer Brown, offering reduced pricing until October 17 for the November 12 event at the Hilton Salt Lake City Center. The summit, which typically attracts over 500 registrants, convenes life sciences leaders, experts, policymakers, and professionals to discuss industry dynamics, regulatory landscapes, market trends, and innovation strategies. Register at https://bioutah.org/summit for early bird discounts and view the preliminary agenda at https://bioutah.org/agenda.
The significance of this gathering extends beyond networking opportunities, as Utah has emerged as one of the nation's fastest-growing life sciences hubs, contributing $22.6 billion to Utah's GDP and supporting approximately 180,000 jobs. Kelvyn Cullimore, president and CEO of BioUtah, emphasized that the event brings together the best and brightest from groundbreaking startups to established industry leaders for discovery, collaboration, and inspiration.
The summit's keynote speaker lineup includes prominent federal regulators who will address critical issues affecting Utah's life sciences ecosystem. Melissa Holyoak, Commissioner of the Federal Trade Commission, brings expertise in consumer protection, constitutional law, healthcare market competition, and mergers and acquisitions. Michelle Tarver, MD, PhD, Director of FDA's Center for Devices and Radiological Health, will conduct a virtual FDA Town Hall discussion about the agency's policy priorities and regulatory initiatives.
Also featured is Peter Marks, MD, former head of the FDA's Center for Biologics Evaluation and Research, who oversaw rapid expansion in FDA-approved cell and gene therapies and played a key role in establishing Operation Warp Speed for COVID-19 vaccine development. Carter Dredge, Executive Director of the Intermountain Health Institute, rounds out the keynote speakers as a global healthcare thought leader known for creating novel solutions to complex problems.
The event's structured networking program during lunch facilitates meaningful professional connections, while specialized tracks cover workforce development, market access, regulatory and quality issues, and legal considerations. BioUtah will also present awards recognizing valuable contributions and achievements in the life sciences sector throughout the day. Cullimore noted that regardless of whether participants focus on medical device manufacturing, diagnostics, or biopharmaceuticals, they will find relevant and engaging content at the summit that addresses the evolving challenges and opportunities in healthcare innovation.